Health

England Launches World's First Gonorrhea Vaccine Program

Published MAY 21 2025

Story

Above: General view of Basingstoke and North Hampshire Hospital. Image credit: Andrew Matthews/PA Images via Getty Images

The Facts

England will become the first country globally to implement a gonorrhea vaccination program starting in August, using the existing meningococcal B vaccine (4CMenB), which offers up to 40% protection against gonorrhea infection.
Health Tech World
Independent
The program targets primarily gay and bisexual men with multiple partners or previous sexually transmitted infections (STIs), after gonorrhea cases in England reached a record-high of 85,000 in 2023, triple the number from 2012.
BBC News
Nursing in Practice
Local health authorities will identify and contact eligible individuals through sexual health services, and offer additional vaccinations for mpox, hepatitis A and B, and HPV during the same appointment.
Sky News
National Health Executive
Analysis by Imperial College London suggests that if high uptake is achieved, the vaccine program could prevent 100,000 gonorrhea cases and save the NHS approximately 7.9 million pounds over the next decade.
Nhs.Uk
Guardian
The initiative specifically aims to combat increasing antibiotic-resistant strains of gonorrhea. The UK Health Security Agency reported 17 cases of ceftriaxone-resistant gonorrhea between January 2024 and March 2025.
Guardian
Daily Mail
Gonorrhea, the second most common bacterial STI in England, can cause serious complications, including eye, testicular, and prostate infections if left untreated, though not all patients experience symptoms.
Independent
Barrons
Daily Mail

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Pro-government narrative

The vaccination program is a groundbreaking public health achievement, highlighting the NHS' global preventive care leadership. This innovative approach could dramatically reduce transmission rates and protect vulnerable populations while addressing the growing threat of antibiotic resistance. The initiative's cost-effectiveness and potential to prevent 100,000 cases make it an astute investment in public health.

Nhs.Uk

Guardian

Government-critical narrative

The program's limited scope, focusing primarily on gay and bisexual men, raises concerns about equitable access to prevention. With gonorrhea affecting diverse populations, including young people aged 16-25 and those of black and Caribbean ancestry, the targeted approach might miss opportunities to protect other high-risk groups. The vaccine's modest 40% effectiveness rate also means it cannot replace other prevention methods.

Sky News

BBC News